cota

Overview

COTA, founded in 2011, is a healthcare company specializing in oncology-focused real-world data (RWD) and analytics. Headquartered in New York, COTA aims to improve cancer care by providing detailed, real-world patient data to support research and development, regulatory, commercial, and health economics and outcomes research (HEOR) teams. The firm's mission is to create clarity from fragmented and inaccessible oncology data, ultimately transforming cancer care.

Key Solutions and Offerings

• Oncology Research and Development: COTA aids drug development teams using a comprehensive database of patient data to expedite timelines, generate hypotheses, identify predictors of treatment response, and inform research decisions.

• Regulatory Support: COTA's data supports regulatory submissions and augments clinical trials, offering real-world benchmarks and external validity.

• Commercial Strategy Validation: Post-approval, COTA's data validates commercial strategy hypotheses, supports label expansions, and conducts Phase IV studies.

• HEOR Studies: COTA enables essential post-marketing studies to validate safety and patient outcomes.

• Data Insights and Analytics: COTA's curated dataset provides insights across various cancer types, treatment settings, and demographics, utilized by cancer centers to streamline Electronic Health Record (EHR) data.

Strategic Partnerships

COTA collaborates with leading biopharmaceutical companies and healthcare providers, ensuring top-quality data. Notable partnerships include Guardant Health Inc., enhancing precision oncology research through clinicogenomic data and AI analytics.

Leadership Team

• Miruna Sasu, President & CEO: Focuses on diversity and precision oncology, steering COTA towards innovative real-world data applications.

• Andrew Pecora, Founder & Chairman: Esteemed in oncology, provides strategic direction and thought leadership.

• C.K. Wang, Chief Medical Officer: Leads medical innovations at the intersection of real-world data and evidence-based healthcare.

• Monica Matta, COO: Manages operations and delivery, ensuring timely and accurate customer data services.

• Ritu Uppal Bahal, CFO: Directs financial strategy and growth, pivotal for COTA's fiscal operations.

• Jaimee Ryan, SVP, Marketing: Drives marketing initiatives, enhancing brand growth and market presence.

Market Position and Achievements

• Fierce 15 Recognition: Included in FierceHealthcare's 2020 Fierce 15 companies.

• Growth and Innovation: Announced new data platforms to advance cancer research and AI models.

• Diverse Leadership: Notably diverse with significant representation of women and non-white executives.

Competitor Profiling

COTA Healthcare operates in a highly competitive field with 33 competitors. Key competitors include Flatiron Health, Tempus, and Fabric Genomics, each known for their technological advancements and services.

Flatiron Health

• Focus: Specializes in improving cancer care through oncology and real-world evidence.

• Background: Founded in 2012, acquired by Roche in 2018, strives to connect cancer care with research globally.

• Leadership and Location: CEO Carolyn Starrett, headquartered in New York, NY.

Tempus

• Focus: AI-enabled precision medicine, boasting the largest library of clinical and molecular data.

• Background: Founded in 2015 by Eric Lefkofsky, it facilitates insights in precision medicine.

• Market Position and Operations: With a $9.7 billion market cap and 2,400 employees, headquartered in Chicago, IL.

Fabric Genomics

• Focus: Leader in genomic analysis using AI, particularly in NGS analysis and clinical reporting.

• Innovation and Leadership: Rapid genome analysis; led by Martin Reese, PhD, Co-Founder, President, and CEO.

Aetion

• Focus: Provides analytics solutions, emphasizing real-world evidence for critical decision-making.

• Technological Strength: The Aetion Evidence Platform® is central to healthcare decision support.

Market and Industry Insights

COTA is part of a competitive landscape marked by rapid technological advancements and collaborations in oncology care and precision medicine. Competitors like Flatiron Health, Tempus, Fabric Genomics, and Aetion focus on large-scale data integration, AI solutions, and real-world evidence to improve healthcare outcomes. These competitors are driving innovation and represent significant challenges and opportunities for COTA. Understanding their strategies and technological emphases is crucial for COTA's strategic planning and success in this dynamic market.